fbpx

Arthrosamid: A Bridge Option to Delay Surgery and Improve Quality of Life in Moderate Knee Osteoarthritis

Arthrosamid, an injectable polyacrylamide hydrogel, offers a promising non-surgical treatment for moderate knee osteoarthritis (OA), providing pain relief and improved joint function. This innovative gel mimics natural joint lubrication, reducing friction and stiffness, potentially delaying the need for surgery by up to two years. Especially beneficial for active adults seeking alternatives to knee replacement, Arthrosamid supports maintaining mobility and quality of life. Clinical studies confirm its safety and efficacy, with personalized care recommended to optimize outcomes. Consult healthcare professionals to explore Arthrosamid and other non-invasive options before considering surgical interventions.

Read More

Unlocking Easier Mornings: How Arthrosamid Supports Stiffness-Dominant Knee OA for Improved Morning Mobility

Morning stiffness significantly impacts those with stiffness-dominant knee osteoarthritis (OA), hindering daily movement and comfort. Arthrosamid, a novel polyacrylamide hydrogel injection, enhances joint lubrication and cushioning, reducing stiffness and improving mobility, especially after rest. Clinical studies demonstrate Arthrosamid’s safety and efficacy for at least two years, making it a promising non-surgical treatment. At MSK Doctors, experts like Professor Paul Lee integrate Arthrosamid with physiotherapy and lifestyle management, emphasizing personalized, multidisciplinary care for optimal outcomes. This approach helps patients regain smoother morning routines and better quality of life. Consultation with qualified clinicians is essential to tailor care to individual needs.

Read More

Copyright Content © 2026 Lincolnshire Hip Clinic